Drug manufacturers who need to report or certify their data must apply for access to the Medicaid Drug Data Reporting (DDR) System. States wishing to view select Medicaid Drug Rebate data also may apply for DDR access. Note: Access to data will be designated by each drug manufacturer's Technical Contact (TC) or State DDR Contact (SDC).
Drug manufacturers who would like to request a new National Drug Rebate Agreement (NDRA) or a reinstatement into the program should follow the instructions found on the Medicaid National Drug Rebate Agreement (NDRA) page.
States who require access to the Drug Utilization Review (DUR) Surveys must obtain access to the Medicaid Drug Program (MDP) system.
Access to both DDR and MDP are obtained in the same manner. For detailed instructions and screenshots for all DDR and MDP related CMS Enterprise Identity Management system (EIDM) tasks, including requesting access, please refer to the EIDM Instruction Guide for DDR Users (PDF, 3.26 MB).
If you have any questions or concerns regarding access to DDR or MDP, please email the DDR/MDP Access Team at DDR@cms.hhs.gov or contact the DDR/MDP EIDM Help Desk at DDRHelpDesk@dcca.com or 1-833-879-6075.
Questions on the Medicaid Drug Rebate Program? Email MDROperations@cms.hhs.gov.
Disclaimer: Please note that the information provided on this web page does not bind or obligate the Centers for Medicare and Medicaid Services (CMS). The statements included on this web page are intended to provide information on the Drug Data Reporting and Medicaid Drug Program Systems and do not in any way revise or modify the requirements set forth in Section 1927 of the Act, the national drug rebate agreement (NDRA), subsequent program releases, or regulations.Page last updated on January 22, 2021